| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8d29a918d7ec83cea80d61d1dbc478cf |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-93 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 |
| filingDate |
2012-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2014-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8b456bdb6f97ebccf6764b186b76bda
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97f8385f8c09ccf1fba2bae9225a3c23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9f435939dfa58b2115c64ab5f2f0b21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87c8ec59d6a85995b75aca3fc7d3eeb8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e1479b306fd85da16f1ab468b3194bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d94aacb43faece11603b51f26f758f2 |
| publicationDate |
2014-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-102964434-B |
| titleOfInvention |
Recombinant encephalitis B virus and application thereof |
| abstract |
The invention discloses a recombinant encephalitis B virus and application thereof. The invention provides a protein which is obtained by mutating a 218th-site amino acid residue on an N terminal of the protein shown as a sequence 3 of a sequence table from a polar amino acid to a non-polar amino acid. The invention also discloses a gene coding the protein, a recombinant expression vector containing the gene, an expression cassette, a transgenic cell line, and a recombinant virus or recombinant bacterium. The invention also discloses an encephalitis B virus vaccine of which the active ingredient is the recombinant virus. The recombinant encephalitis B virus provided by the invention can be used as the encephalitis B virus vaccine, and has a better application prospect in prevention of the encephalitis B virus infection. |
| priorityDate |
2012-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |